Coleman C

Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022
Bingham JL, Cable R, Coleman C, Glatt TN, Grebe PE, Mhlanga L, Nyano C, Pieterson N, Swanevelder R, Swarts A, Sykes W, van den Berg K, Vermeulen M, Welte A

medRxiv

(2022)

https://doi.org/10.21203/rs.3.rs-1687679/v2
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021
Cable R, Coleman C, Glatt T, Grebe PE, Mhlanga L, Nyano C, Pieterson N, Swanevelder R, Swarts A, Sykes W, van den Berg K, Vermeulen M, Welte A

medRxiv

(2022)

https://doi.org/10.21203/rs.3.rs-1359658/v1
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021
Sykes W, Mhlanga L, Swanevelder R, Glatt TN, Grebe PE, Coleman C, Pieterson N, Cable R, Welte A, van den Berg K, Vermeulen M

Research Square

(2021)

https://doi.org/10.21203/rs.3.rs-233375/v1
Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes
Vermeulen M, Lelie N, Coleman C, Sykes N, Jacobs G, Swanevelder R, Busch MP, van Zyl G, Grebe PE, Welte A, Reddy R

Transfusion

(2019)

https://doi.org/10.1111/trf.14959